BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

472 related articles for article (PubMed ID: 27170339)

  • 1. Oral vitamin C supplementation reduces erythropoietin requirement in hemodialysis patients with functional iron deficiency.
    Sultana T; DeVita MV; Michelis MF
    Int Urol Nephrol; 2016 Sep; 48(9):1519-24. PubMed ID: 27170339
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of intravenous ascorbic acid in hemodialysis patients with EPO-hyporesponsive anemia and hyperferritinemia.
    Attallah N; Osman-Malik Y; Frinak S; Besarab A
    Am J Kidney Dis; 2006 Apr; 47(4):644-54. PubMed ID: 16564942
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of an intravenous iron dextran regimen on iron stores, hemoglobin, and erythropoietin requirements in hemodialysis patients.
    Park L; Uhthoff T; Tierney M; Nadler S
    Am J Kidney Dis; 1998 May; 31(5):835-40. PubMed ID: 9590194
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intravenous ascorbic acid as an adjuvant therapy for recombinant erythropoietin in hemodialysis patients with hyperferritinemia.
    Tarng DC; Wei YH; Huang TP; Kuo BI; Yang WC
    Kidney Int; 1999 Jun; 55(6):2477-86. PubMed ID: 10354297
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 2008 Japanese Society for Dialysis Therapy: guidelines for renal anemia in chronic kidney disease.
    Tsubakihara Y; Nishi S; Akiba T; Hirakata H; Iseki K; Kubota M; Kuriyama S; Komatsu Y; Suzuki M; Nakai S; Hattori M; Babazono T; Hiramatsu M; Yamamoto H; Bessho M; Akizawa T
    Ther Apher Dial; 2010 Jun; 14(3):240-75. PubMed ID: 20609178
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oral use of iron with vitamin C in hemodialyzed patients.
    Mydlík M; Derzsiová K; Boldizsár J; Hríbiková M; Petrovicová J
    J Ren Nutr; 2003 Jan; 13(1):47-51. PubMed ID: 12563623
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of intravenous ascorbic acid in hemodialysis patients with anemia and hyperferritinemia.
    Shahrbanoo K; Taziki O
    Saudi J Kidney Dis Transpl; 2008 Nov; 19(6):933-6. PubMed ID: 18974579
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy and safety of a low monthly dose of intravenous iron sucrose in peritoneal dialysis patients.
    Mitsopoulos E; Lysitska A; Pateinakis P; Lamprou V; Intzevidou E; Minasidis I; Katsaounou C; Kougioumtzidou O; Anagnostou N; Lemonidis N; Papadopoulou D
    Int Urol Nephrol; 2020 Feb; 52(2):387-392. PubMed ID: 31894555
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oral zinc supplementation reduces the erythropoietin responsiveness index in patients on hemodialysis.
    Kobayashi H; Abe M; Okada K; Tei R; Maruyama N; Kikuchi F; Higuchi T; Soma M
    Nutrients; 2015 May; 7(5):3783-95. PubMed ID: 25988769
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of intravenous iron supplementation on erythropoiesis in erythropoietin-treated premature infants.
    Pollak A; Hayde M; Hayn M; Herkner K; Lombard KA; Lubec G; Weninger M; Widness JA
    Pediatrics; 2001 Jan; 107(1):78-85. PubMed ID: 11134438
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Randomized, crossover study of the effect of vitamin C on EPO response in hemodialysis patients.
    Keven K; Kutlay S; Nergizoglu G; Ertürk S
    Am J Kidney Dis; 2003 Jun; 41(6):1233-9. PubMed ID: 12776276
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Erythropoietin requirements: a comparative multicenter study between peritoneal dialysis and hemodialysis.
    Coronel F; Herrero JA; Montenegro J; Fernandez C; Gandara A; Conesa J; Rivera MT; Torrente J; Portolés J; Gomez-Martino JR
    J Nephrol; 2003; 16(5):697-702. PubMed ID: 14733416
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Red cell ferritin, a marker of iron deficiency in hemodialysis patients.
    Bhandari S; Owda AK; Kendall RG; Moran N; Norfolk DR; Brownjohn AM; Turney JH
    Ren Fail; 1997 Nov; 19(6):771-80. PubMed ID: 9415934
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vitamin A supplementation in children with poor vitamin A and iron status increases erythropoietin and hemoglobin concentrations without changing total body iron.
    Zimmermann MB; Biebinger R; Rohner F; Dib A; Zeder C; Hurrell RF; Chaouki N
    Am J Clin Nutr; 2006 Sep; 84(3):580-6. PubMed ID: 16960172
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Beneficial hematologic effects of daily oral ascorbic acid therapy in ESRD patients with anemia and abnormal iron homeostasis: a preliminary study.
    Sirover WD; Siddiqui AA; Benz RL
    Ren Fail; 2008; 30(9):884-9. PubMed ID: 18925528
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ergocalciferol treatment does Not improve erythropoietin utilization and hospitalization rate in hemodialysis patients.
    Agarwal G; Hirachan P; Gelfond J; Fanti P; Hura C; Bansal S
    BMC Nephrol; 2016 Oct; 17(1):144. PubMed ID: 27717322
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Low dose intravenous ascorbic acid for erythropoietin-hyporesponsive anemia in diabetic hemodialysis patients with iron overload.
    Lin CL; Hsu PY; Yang HY; Huang CC
    Ren Fail; 2003 May; 25(3):445-53. PubMed ID: 12803508
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intravenous ascorbic acid in hemodialysis patients with functional iron deficiency: a clinical trial.
    Giancaspro V; Nuzziello M; Pallotta G; Sacchetti A; Petrarulo F
    J Nephrol; 2000; 13(6):444-9. PubMed ID: 11132761
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intravenous iron sucrose in Chinese hemodialysis patients with renal anemia.
    Li H; Wang SX
    Blood Purif; 2008; 26(2):151-6. PubMed ID: 18212498
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Functional iron deficiency in hemodialysis patients with high ferritin.
    Kopelman RC; Smith L; Peoples L; Biesecker R; Rizkala AR
    Hemodial Int; 2007 Apr; 11(2):238-46. PubMed ID: 17403177
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.